EcoDrugPlus

Ensembl ID : ML088211a
Gene Symbol: -
External references: -
765 Possible Orthologues:

Ensembl ID : ML089410a
Gene Symbol: -
External references: -
58 Possible Orthologues:

Ensembl ID : ML089714a
Gene Symbol: -
External references: -
167 Possible Orthologues:

Ensembl ID : ML090118a
Gene Symbol: -
External references: -
95 Possible Orthologues:

Ensembl ID : ML09068a
Gene Symbol: -
External references: -
104 Possible Orthologues:

Ensembl ID : ML09424a
Gene Symbol: -
External references: -
87 Possible Orthologues:

Ensembl ID : ML09425a
Gene Symbol: -
External references: -
262 Possible Orthologues:

Ensembl ID : ML09436a
Gene Symbol: -
External references: -
104 Possible Orthologues:

Ensembl ID : ML09514a
Gene Symbol: -
External references: -
239 Possible Orthologues:

Ensembl ID : ML095310a
Gene Symbol: -
External references: -
342 Possible Orthologues:

Ensembl ID : ML09548a
Gene Symbol: -
External references: -
193 Possible Orthologues:

Ensembl ID : ML09839a
Gene Symbol: -
External references: -
117 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).